Results

Total Results: 2,098 records

Showing results for "study".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4.pdf
    January 01, 2023 - Period: February 27, 2024, to April 28, 2024 Summary: During the current search period, one new study … The new study was assessed as high risk of bias and had a small sample size (n=60). … New studies identified since the 2023 systematic review Search Period Citation Risk of Bias N Study … Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study. … High 296 Prospective cohort Note: The first study listed is in bold because it was identified in
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
    May 01, 2025 - For each included primary study, we extracted the following information: • General study characteristics … : author, year of publication, country, funding source • Study design: study design, study population … overview of the study design and population characteristics of the included primary study. … Since this study was a retrospective cohort study, we used the Newcastle Ottawa Scale to assess its … Risk of Bias Assessments The included study was a retrospective cohort study.
  3. effectivehealthcare.ahrq.gov/sites/default/files/hawley-presentation.pdf
    October 08, 2025 - The  first study is a  population-­based  study of colorectal cancer patients in  Atlanta   and Detroit … This study was focused  on trying  to   understand  reasons for differences in  receipt of chemo  therapy … One  is a  completed  study and  one is a  current study, again, both   population-­based, both  oversampling … We  were  specifically interested  in  that issue  in  this colorectal cancer study and  had a whole … In  this study we  asked  patients, after they had  completed  their breast cancer treatment, "How
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
    January 01, 2023 - duration or length of follow up • Settings: o No limitation on study setting • Study Design: o … duration and length of follow up None Setting • All study settings None Study Design • RCTs • … If study authors respond and report missing study data, corrections, or other study information relevant … Study-reported inclusion and exclusion criteria Study Characteristics 1. Year of publication 2. … Study class 3. Country/Countries of study sites 4. Site type 5. Clinical setting 6.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - Comparable THC to CBD ratio study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … High THC to CBD ratio study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … Low THC to CBD ratio study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … Other cannabinoids study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … Observational study primary outcomes Author, Year Risk of Bias Study Design Pain Condition Comparison
  6. effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
    August 13, 2012 - These assumptions should be described in the study protocol and in reporting final study results. … when a smaller study may be sufficient. … the final study results. … Challenges to Developing Study Questions and Initial Solutions In developing CER study objectives … questions that the study will answer
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-mental-health_research-protocol.pdf
    September 01, 2016 - reported, retention, study conduct, and other details of study design in the peer reviewed literature … Your study [xxx, has been included/is eligible for inclusion] in this review. … We were unable to find a listing for your study on clinicaltrials.gov. … Is the study listed elsewhere on another clinical trials registry? … [If the study results are not listed in any clinical trials registry] Did you attempt to list your study
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
    November 03, 2011 - of the Efficacy and Safety of Topiramate in the Prevention of Migraine NCT00236561 A Study of the … NCT00665236 Craniosacral Therapy in Migraine: A Feasibility Study NCT00714727 Set Point Acupuncture … in Adolescents NCT00210873 An Open Label Extension of a Study of Topiramate in Chronic Migraine. … Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488. … NCT00850421 Pilot Study of BOTOX for Migraine Headaches NCT00203307 A Research Study Examining the
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
    October 25, 2022 - We included four studies of topiramate and one study of phenytoin. … We included four studies of topiramate and one study of phenytoin. … We included four studies of topiramate and one study of phenytoin. … This study (Roth et al.) was included in the revised report. … One could study Keto diet vs a second or 3rd med.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - , including author, year, study design, number of study participants, and main findings relevant to … Four studies were assessed to be at moderate risk of bias, one study was at low risk, and one study … This study was at moderate risk of bias. … One study of a CRE surveillance PSP also provided support for ASC.22 This pre- post study implemented … Ann Intern Med. 2019 171:S59-S65. – Study design - review 75.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-surgical-report-cards.pdf
    November 01, 2023 - , including author, year, study design, number of study participants, and main findings relevant to … Of these, 9 used a pre-post or longitudinal study design17,20,25-29,31,33 and 4 used stronger studyStudy Quality Assessment Tools. 2020. https://www.nhlbi.nih.gov/health- topics/study-quality-assessment … /study-quality-assessment-tools 19 15. … Study Quality Assessment Tools. 2020. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
    October 08, 2025 - Measurement Attrition Mitigate the Impact of Any Overall and Differential Measurement Attrition in the Study … Other Considerations: Did study report adequate treatment fidelity based on measurement by independent … Notes: Describe additional considerations specific to the study that were factored into the final ROB … used a validated PTSD assessment method No • Used different outcome measures for each study arm Mixed … Yes: • Study reported on treatment fidelity rating No: • Study did not report on treatment fidelity
  13. S158 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
    October 01, 2007 - The main study partici- pants on whom additional data are collected in the validation study can be a … is not an internal validation study in the strict sense of the term, the study clearly contains enough … ‡Models and their relevant parameters from the validation study can be applied to the main study—this … As in our main study, the validation study population was restricted to persons age 65 years or older … Validation Study Main Study Validation Study “Error-Prone” Propensity Score “Error-Prone” Propensity
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-final-protocol.pdf
    October 01, 2022 - duration or length of follow up • Settings: o No limitation on study setting • Study Design: o … duration and length of follow up None Setting • All study settings None Study Design • RCTs • … If study authors respond and report missing study data, corrections, or other study information relevant … Proportion of participants meeting study-defined criteria for PTSD at baseline c. … Proportion of participants who achieved study-defined PTSD diagnostic change j.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - Comparable THC to CBD ratio study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … High THC to CBD ratio study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … Low THC to CBD ratio study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … Other cannabinoids study primary outcomes Author, Year Risk of Bias Study Design Pain Condition … Observational study primary outcomes Author, Year Risk of Bias Study Design Pain Condition Comparison
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-repository-expanded-protocol.pdf
    October 24, 2019 - duration or length of followup • Settings: o No limitation on study setting • Study Design: … duration and length of followup None Setting • All study settings None Study Design • RCTs • … Proportion of participants who achieved study-defined PTSD diagnostic change j. … Did the study use intention-to-treat analysis? j. … Did the study use adequate methods for handling missing data? k.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-executive-summary.pdf
    May 01, 2025 - • We only found one study reporting on potential harms from multicancer screening tests. … We graded the strength of evidence as insufficient for harms based on this single study. … Summary of findings and strength of evidence KQ Test Outcome Number of Studies and Study Design … We only found one study that looked at potential harms. … Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol-2021_0.pdf
    January 01, 2021 - duration or length of follow up • Settings: o No limitation on study setting • Study Design: o … duration and length of follow up None Setting • All study settings None Study Design • RCTs … If study authors respond and report missing study data, corrections, or other study information relevant … Proportion of participants meeting study-defined criteria for PTSD at baseline c. … Proportion of participants who achieved study-defined PTSD diagnostic change j.
  19. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
    January 01, 2023 - Study Type Outcome Result Population Rocha et al. … Primary study Hospital mortality 27% reduction Adults Factora Primary study Hospital mortality 4% average … Arrest 45 Study Study Type Outcome Result Population Rocha et al. … Study Type Modifications Outcome Results Population Dean et al. … Study Type Modification Outcome Results Population Sebat et al.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-immunodeficiency-virus-rapid-response.pdf
    May 01, 2025 - AHRQ did not directly participate in the literature search, determination of study eligibility criteria … For each included primary study, we extracted the following information: • General study characteristics … : author, year of publication, country, funding source • Study design: study design, study population … One study was conducted in the US,30 and two were in Brazil.31,32 Sample sizes were small. … Funding Study Design Sample Size Followup Length Periodontitis Definition Study Inclusion

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: